Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease

David M. Reynolds, Tomohito Hayashi, Yiqiang Cai, Barbera Veldhuisen, Terry J. Watnick, Xose M. Lens, Toshio Mochizuki, Feng Qian, Yoshiko Maeda, Li Li, Ragnheidur Fossdal, Eliecer Coto, Guanqing Wu, Martijn H. Breuning, Gregory G. Germino, Dorien J.M. Peters, Stefan Somlo

Research output: Contribution to journalArticle

Abstract

It is estimated that approximately 15% of families with autosomal dominant polycystic kidney disease (ADPKD) have mutations in PKD2. Identification of these mutations is central to identifying functionally important regions of gene and to understanding the mechanisms underlying the pathogenesis of the disorder. The current study describes mutations in six type 2 ADPKD families. Two single base substitution mutations discovered in the ORF in exon 14 constitute the most COOH-terminal pathogenic variants described to date. One of these mutations is a nonsense change and the other encodes an apparent missense variant. Reverse transcription-PCR from patient lymphoblast RNA showed that, in addition, both mutations resulted in out-of- frame splice variants by activating cryptic splice sites via different mechanisms. The apparent missense variant produced such a strong splicing signal that the processed transcript from the mutant chromosome did not contain any of the normally spliced, missense product. A third mutation, a nonconservative missense change effecting a negatively charged residue in the third transmembrane span, is likely pathogenic and defines a highly conserved residue consistent with a potential channel subunit function for polycystin- 2. The remaining three mutations included two frame shifts resulting from deletion of one or two bases in exons 6 and 10, respectively, and a nonsense mutation due to a single base substitution in exon 4. The study also defined a novel intragenic polymorphism in exon 1 that will be useful in analyzing 'second hits' in PKD2. Finally, the study demonstrates that there are reduced levels of normal polycystin-2 protein in lymphoblast lines from PKD2-affected individuals and that truncated mutant polycystin-2 cannot be detected in patient lymphoblasts, suggesting that the latter may be unstable in at least some tissues. The mutations described will serve as critical reagents for future functional studies in PKD2.

Original languageEnglish (US)
Pages (from-to)2342-2351
Number of pages10
JournalJournal of the American Society of Nephrology
Volume10
Issue number11
StatePublished - Nov 1 1999

    Fingerprint

ASJC Scopus subject areas

  • Nephrology

Cite this

Reynolds, D. M., Hayashi, T., Cai, Y., Veldhuisen, B., Watnick, T. J., Lens, X. M., Mochizuki, T., Qian, F., Maeda, Y., Li, L., Fossdal, R., Coto, E., Wu, G., Breuning, M. H., Germino, G. G., Peters, D. J. M., & Somlo, S. (1999). Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. Journal of the American Society of Nephrology, 10(11), 2342-2351.